170 related articles for article (PubMed ID: 32668474)
1. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial.
Zhang Y; Liu L; Wang Q; Guo L; Ye L; Zeng H; Zeng X; Yuan X; Li Y; Zhang Y; Zhou E; Hu B
Endoscopy; 2020 Dec; 52(12):1066-1074. PubMed ID: 32668474
[TBL] [Abstract][Full Text] [Related]
2. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of endoscopic submucosal dissection with additional radiotherapy for T1a-MM/T1b-SM esophageal squamous cell carcinoma].
Chen YF; Liu SQ; Li MY; Chen R; Shi RH
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3676-3682. PubMed ID: 38018068
[No Abstract] [Full Text] [Related]
4. A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC).
Lu H; Bei Y; Wang C; Deng X; Hu Q; Guo W; Zhang X
PLoS One; 2024; 19(2):e0298792. PubMed ID: 38386660
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
[TBL] [Abstract][Full Text] [Related]
7. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.
Yang X; Zhao L; Shi A; Chen C; Cao J; Zhang Y; Zhu H; Wang J; Zhou W; Li X; Hu S; Men Y; Wang J; Xue L; Liu Y; Dou L; Zhang Y; Sun S; Yuan M; Bao Y; Ma Z; Liu Y; Zhang W; Bi N; Wang G; Hui Z
Am J Gastroenterol; 2023 Aug; 118(8):1344-1352. PubMed ID: 36972240
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic submucosal dissection under general anesthesia for superficial esophageal squamous cell carcinoma is associated with better clinical outcomes.
Song BG; Min YW; Cha RR; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
BMC Gastroenterol; 2018 Jun; 18(1):80. PubMed ID: 29879909
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for intraoperative perforation during endoscopic submucosal dissection of superficial esophageal squamous cell carcinoma.
Noguchi M; Yano T; Kato T; Kadota T; Imajoh M; Morimoto H; Osera S; Yagishita A; Odagaki T; Yoda Y; Oono Y; Ikematsu H; Kaneko K
World J Gastroenterol; 2017 Jan; 23(3):478-485. PubMed ID: 28210084
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of endoscopic submucosal dissection for esophageal squamous cell carcinoma with esophageal varices: Multicenter retrospective study.
Toya Y; Hatta W; Shimada T; Matsuhashi T; Shiroki T; Sasaki Y; Tatsuta T; Nakamura J; Hanabata N; Horikawa Y; Nagino K; Koike T; Masamune A; Harada Y; Ohira T; Iijima K; Abe Y; Hikichi T; Igarashi S; Fushimi S; Takeda H; Fukuda S; Matsumoto T;
Dig Endosc; 2024 Mar; 36(3):314-322. PubMed ID: 37343173
[TBL] [Abstract][Full Text] [Related]
13. Salvage endoscopic resection for cT1N0M0 local recurrence after chemoradiotherapy for esophageal squamous cell carcinoma: endoscopic submucosal dissection versus endoscopic mucosal resection.
Nakajo K; Yoda Y; Yamashita H; Takashima K; Murano T; Kadota T; Shinmura K; Ikematsu H; Akimoto T; Yano T
Jpn J Clin Oncol; 2022 Sep; 52(9):982-991. PubMed ID: 35675653
[TBL] [Abstract][Full Text] [Related]
14. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
[TBL] [Abstract][Full Text] [Related]
15. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y
Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma with Relative Indications.
Liu Y; Qian D; Tang B; Fan C; Yu J; Lin H; Bai J; Zhao X
Dig Surg; 2021; 38(1):14-23. PubMed ID: 33271540
[TBL] [Abstract][Full Text] [Related]
17. Local recurrence risk of esophageal squamous cell carcinoma due to intralesional damage during endoscopic submucosal dissection.
Minamide T; Kawata N; Maeda Y; Yoshida M; Yamamoto Y; Ashizawa H; Takada K; Kishida Y; Ito S; Imai K; Hotta K; Sato J; Ishiwatari H; Matsubayashi H; Sugino T; Ono H
J Gastroenterol Hepatol; 2023 Oct; 38(10):1802-1807. PubMed ID: 37519057
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
Yoshii T; Ohkawa S; Tamai S; Kameda Y
Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Follow-Up Observation After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa Without Lymphovascular Involvement.
Iwai N; Dohi O; Yamada S; Ishida T; Fukui A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Yagi N; Naito Y; Itoh Y
Dig Dis Sci; 2023 Sep; 68(9):3679-3687. PubMed ID: 37470897
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of endoscopic aspiration mucosectomy and endoscopic submucosal dissection in patients with superficial esophageal squamous-cell carcinoma.
Furue Y; Katada C; Tanabe S; Ishido K; Kondo Y; Kubota Y; Kawanishi N; Yamane S; Watanabe A; Moriya H; Yamashita K; Wada T; Yano T; Azuma M; Koizumi W
Surg Endosc; 2019 May; 33(5):1433-1440. PubMed ID: 30187201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
